Skip to content

Telomeres Evaluation in Endometriosis

Telomeres Evaluation in Endometriosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01809561
Enrollment
30
Registered
2013-03-12
Start date
2013-05-31
Completion date
2015-02-28
Last updated
2013-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

endometriosis, telomere, telomerase

Brief summary

The purpose of the study is to assess the telomere array of different endometriosis tissue and endometrium from women with endometriosis compared to healthy women. Our hypothesis is that telomere shortening and high telomerase activity will be found in tissues from women with endometriosis.

Detailed description

The purpose of the study is to assess the telomere array of different endometriosis tissue and endometrium from women with endometriosis compared to healthy women. Our hypothesis is that telomere shortening and high telomerase activity will be found in tissues from women with endometriosis, compared to women without endometriosis. A prospective study that compares telomeres and telomerase levels in different lesions of endometriosis and endometrial tissue of women with endometriosis and healthy women without endometriosis. The study group will consist of women with suspected endometriosis facing surgical treatment and the control group will consist of healthy women facing gynecologic surgery for different indication. We will sample endometrial tissue in both groups. In the study group we additionally will sample endometriosis lesion. The samples collected will test for histological diagnosis of endometriosis and verification tests will be done to characterize the telomeres array and telomerase levels and other characteristics for genomic instability such as spontaneous aneuploidy. expect telomere shortening and high telomerase activity in endometrial tissue and in endometriosis tissue sample, that won't characterize samples from women without endometriosis.

Interventions

PROCEDUREtissue biopsy during surgical treatment

The samples collected will test for histological diagnosis of endometriosis and verification tests will be done to characterize the telomeres array and telomerase levels and other characteristics for genomic instability such as spontaneous aneuploidy.

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* women with suspected endometriosis facing surgical treatment

Exclusion criteria

* no endometriosis on histology * malignant finding on histology

Design outcomes

Primary

MeasureTime frame
characterize the telomeres array and telomerase levels and other characteristics for genomic instability such as spontaneous aneuploidy in endometriosis tissue.the tissue sample will colect at time of surgery

Countries

Israel

Contacts

Primary ContactMerav Sharvit, DR
merav.sharvit@gmail.com972-9-7472561

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026